Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108299296A details a visible-light induced synthesis of phenanthridine derivatives using organic photocatalysts, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Advanced synthesis of chiral spiro bisphosphine ligands via Pd-catalyzed coupling. Delivers high-purity intermediates for asymmetric catalysis with scalable manufacturing.
Patent CN113087742B details a novel synthesis for phosphine chiral center compounds using stable oxides. Enables cost-effective production of high-purity catalysts.
Patent CN114409515B reveals a metal-free route to gem-difluoroalkenes using diphenylphosphine oxide, offering cost-effective manufacturing for pharma intermediates.
Patent CN116768904B reveals high-yield chiral synthesis. Offers cost reduction and supply reliability for antitumor intermediates. Enables scalable manufacturing processes.
Patent CN114315536A reveals a metal-free method for synthesizing axial chiral diarylethenes with high enantioselectivity, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114853692B reveals a novel solvent-free catalytic route for 2-aminothiazole, delivering >95% yield and 99% purity while drastically reducing manufacturing costs.
Patent CN107880039B reveals a heavy-metal-free route for pyrido triazinone compounds. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114436836B reveals a cost-effective copper-catalyzed synthesis for Tolterodine intermediates, offering high enantioselectivity and supply chain advantages.
Patent CN106146418B reveals a metal-free one-pot route for high-purity NH-1,2,3-triazole. This method offers substantial cost reduction in API intermediate manufacturing and supply chain reliability.
Patent CN114213254B details a visible-light mediated synthesis of beta-nitroketones. Offers high yield, mild conditions, and scalable routes for pharmaceutical intermediates.
Patent CN111072605B details a visible-light catalyzed method for fluoroalkyl-substituted benzofurans. Offers mild conditions and high yields for pharma intermediates.
Novel quinoline-substituted bisoxazoline ligand enables high enantioselectivity in trifluoromethylation. Offers scalable synthesis and cost-effective supply chain solutions for pharmaceutical intermediates.
Novel Mo/Cu co-catalyzed method for 3-trifluoromethyl-1,2,4-triazoles offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN115093315B reveals a novel inorganic salt-catalyzed route for 2-benzylidene-3-cyclohexenone, offering cost-effective and scalable pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates with scalable cost reduction and supply chain reliability ensuring consistent quality for global drug development pipelines.
Patent CN116041393B reveals a novel N-N axis chiral bis-indole phosphine ligand synthesis offering superior stereoselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with mild conditions and scalable supply chain reliability for global partners.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Novel FeCl3-catalyzed route for quinazolinones offers high yields and cost efficiency for pharmaceutical intermediate manufacturing and supply chain stability.